Up to 60% of ophthalmologist patients have some form of ocular surface disease impacting over 60 million Americans.
A Gallop poll of dry eye sufferers shows:
- 72% of patients use an artificial tear.
- 82% wish that there was something more effective to treat dry eye.
- 97% say that their dry eye condition is frustrating.
The discussion starts with the answer to this question posed by James Mazzo: “So why is there such a under-diagnosis of dry eye if your patients are clamoring for some kind of treatment?”
Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved.
Edward Holland, MD
Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Clinical Ophthalmology at the University of Cincinnati.
Eric Donnenfeld, MD
Dr. Donnenfeld is a Clinical Professor of Ophthalmology at NYU, Trustee of Dartmouth Medical School, and founding partner of Ophthalmic Consultants of Long Island.
Vance Thompson, MD
Vance Thompson, MD is an internationally recognized specialist in Laser Vision Correction and Advanced Cataract Surgery. As a leading international researcher he has played a key role in the development of the most advanced technologies and techniques for both laser and implant vision correction.
Roger Steinert, MD
Dr. Steinert’s advanced skill and excellent surgical results have earned him a reputation as an international consultant and leader in cataract surgery, refractive surgery and corneal transplants.